Cargando…
Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis
BACKGROUND: We aimed to identify associations between erythroferrone (ERFE), a regulator of hepcidin 25, and biomarkers of erythropoiesis and iron metabolism. We also aimed to determine the effects of erythropoiesis-stimulating agents (ESA), continuous erythropoietin receptor activator (CERA) and da...
Autores principales: | Honda, Hirokazu, Kobayashi, Yasuna, Onuma, Shoko, Shibagaki, Keigo, Yuza, Toshitaka, Hirao, Keiichi, Yamamoto, Toshinori, Tomosugi, Naohisa, Shibata, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792384/ https://www.ncbi.nlm.nih.gov/pubmed/26978524 http://dx.doi.org/10.1371/journal.pone.0151601 |
Ejemplares similares
-
Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis
por: Yoshida, Shunsuke, et al.
Publicado: (2023) -
Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2020) -
The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry
por: Castro-Mollo, Melanie, et al.
Publicado: (2021) -
Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia
por: Olivera, Joseph, et al.
Publicado: (2023) -
Tips for erythropoiesis-stimulating agent treatment of renal anemia
por: Tomosugi, Naohisa, et al.
Publicado: (2019)